Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Role of Family Planning in Women with MS

Front Neurol; ePub 2018 Oct 10; Kamm, et al

Women with multiple sclerosis (MS) received disease-modifying drug (DMD) treatment and the type of DMD treatment was influenced by family planning, with significantly more women with a short-term plan to conceive using injectables. This according to a recent study that aimed to better understand the effect of family planning on treatment decisions in female patients with MS. It illustrated that pregnancy remains an important, yet unresolved, concern in the treatment of MS patients. Female patients with MS (aged 18–55 years) participated in a 26-question survey between September 2014 and August 2015. Researchers found:

  • In total, 271 questionnaires distributed from 15 MS centers were returned for analysis.
  • Of these, 250 (92.3%) participants received DMD therapy and 106 (39.1%) wanted children or were pregnant.
  • Significantly more patients with a short-term plan to conceive within 2 years were treated with injectables (19/54) compared with those without a plan to conceive (19/108).


Kamm CP, Muehl S, Mirscof D, et al. Role of family planning in women with multiple sclerosis in Switzerland: Results of the Women with Multiple Sclerosis patient survey. [Published online ahead of print October 10, 2018]. Front Neurol. doi:10.3389/fneur.2018.00821.